Clinically Mild Encephalopathy With a Reversible Splenial Lesion Type 2 Caused by Human Herpesvirus 6 Infection

Fumikazu Sano1, Toshimichi Fukao1, Kei Tamaru1

  • 1Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Pediatric Neurology
|October 4, 2020
PubMed
Abstract

Insights

Human herpesvirus 6 (HHV6) can cause mild encephalopathy with a reversible splenial lesion type 2 (MERS-2). This case report details the first instance of HHV6-induced MERS-2, expanding understanding of MERS-2 pathogenesis.

Area of Science:

  • Neurology
  • Virology
  • Pediatrics

Background:

  • Mild encephalopathy with reversible splenial lesion (MERS) is a common neurological condition.
  • MERS type 2 has been linked to various pathogens, but the causative agents are not fully understood.
  • Human herpesvirus 6 (HHV6) is a known cause of acute encephalopathy, but its role in MERS type 2 was previously unreported.

Observation:

  • A five-year-old boy presented with symptoms consistent with MERS type 2.
  • Diagnostic investigations, including viral testing and neuroimaging, confirmed HHV6 infection as the cause.
  • The patient's clinical course and findings were characteristic of MERS type 2.

Findings:

  • This report provides the first documented case of MERS type 2 caused by Human herpesvirus 6 (HHV6) infection.
  • The study establishes a link between HHV6 and MERS type 2, a connection not previously detailed in medical literature.
  • Clinical findings associated with HHV6-induced MERS type 2 are now better understood.

Implications:

  • HHV6 should be considered as a potential cause of MERS type 2.
  • This finding contributes to the etiological understanding of MERS type 2.
  • Further research is warranted to explore the prevalence and clinical spectrum of HHV6-related MERS type 2.

Related Concept Videos